Tag: Chemotherapy
ASH: Blinatumomab + Chemo Aids Survival in B-Cell Acute Lymphoblastic Leukemia
Estimated disease-free survival 97.5 ± 1.3 and 90.2 ± 2.3 percent with chemotherapy plus blinatumomab, chemo alone in average-risk patients
Survival Up With Nivolumab + Ipilimumab Versus Chemo for Metastatic CRC
Findings seen in patients with microsatellite-instability-high or mismatch-repair-deficient metastatic colorectal cancer
ChemoRT Then Immunochemotherapy Then Surgery Promising in Unresectable Esophageal Cancer
One-year progression-free survival, overall survival was 79.4, 89.6 percent; significantly longer survival seen in patients who achieved resectability
Multigene Signature Can Help Tailor Chemo for Operable Triple-Negative Breast Cancer
Improved three-year disease-free and recurrence-free survival seen with intensive chemotherapy regimen
Restaging MRI Can Predict Survival With Rectal Cancer
Findings can save some lower-risk patients surgery after chemo, radiation
FDA Approves Vyloy for Advanced Gastric or Gastroesophageal Junction Cancer
Vyloy is the first and only CLDN18.2-targeted therapy approved in the United States
No Objective Improvement Seen in Cognitive Function With Exercise During Chemo
Significant differences seen in four of six self-reported cognitive function outcomes favoring aerobic exercise initiated with chemo
Pembrolizumab Aids Survival With High-Risk Endometrial Cancer
Findings seen in combination with chemotherapy following surgery in patients with curative intent
Olanzapine, Prochlorperazine Both Alleviate Refractory Chemo-Related Nausea
Findings seen for patients with breast cancer starting a high/moderate emetogenic chemotherapy regimen
2023 Cisplatin Shortage Tied to Use of Alternatives for Head, Neck Cancer
Alternative treatments came at significantly higher costs for both payers, patients
